(Fighting New Coronary Pneumonia) The first round of large-scale nucleic acid test sampling results of Jiangxi Qianshan are all negative
China News Service, Shangrao, Jiangxi, November 1st (Reporter Wu Pengquan) The reporter learned from the press conference on the prevention and control of the new crown pneumonia epidemic in Shangrao City, Jiangxi Province. In the large-scale nucleic acid testing work, a total of 29,3062 people were tested (including 135,820 people in Gexianshan Town, Hufang Town, and Hekou Town in key areas), and the test results were all negative.
On October 30, Qianshan County, Shangrao City, Jiangxi Province, added a new confirmed case of new coronary pneumonia. The confirmed case had previously worked at the Xiancun Guest House Restaurant in Gexian Village Resort, Qianshan County.
On October 31, Jiangxi reported 1 new locally confirmed case-related case and 4 new asymptomatic infections, all of whom were close contacts of the confirmed cases in Qianshan County.
The Jiangxi Provincial Health Commission reported on the evening of October 31 that the above-mentioned newly confirmed cases, close contacts of asymptomatic infections, and close contacts of close contacts have all taken control measures such as centralized isolation and medical observation.
According to Zhang Wei, the leader of the high-level expert team of the Jiangxi New Crown Pneumonia Epidemic Prevention and Control Emergency Command and the dean of the First Affiliated Hospital of Nanchang University, as of 24:00 on October 31, Qianshan has 1 case of mildly confirmed patients and 4 cases of none. There are no severe patients with symptomatic infections, and most of them are immediate family members or roommates.
According to the expert group's assessment, the patient's condition is controllable as a whole.
Wang Jinfu, director of the Shangrao Municipal Health Commission, said that in order to strengthen risk control, detect potentially infected people as soon as possible, and cut off the transmission chain, Jiangxi Qianshan will continue to carry out the second round of large-scale nucleic acid testing in the next step.
(over)